Mitchell Chan
Chief Financial Officer; Director · 3 filings · Latest: Sep 1, 2026
Avalo Therapeutics, Inc.
REGENXBIO Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
AVTX | Mitchell Chan | Director | May 6, 2026 | Sale | $22.88 | 3,167 | $72.5K | 3,166 | |
AVTX | MITCHELL CHAN | — | May 6, 2026 | Proposed Sale | $16.26 | 3,167 | $51.5K | — | |
AVTX | Mitchell Chan | Director | Mar 28, 2026 | Option Exercise | — | 3,166 | — | 6,333 | |